Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Nov;20(6):650-1.
doi: 10.1097/CCO.0b013e328313e188.

Editorial review: targets for glioma treatment: from bench to bedside

Review

Editorial review: targets for glioma treatment: from bench to bedside

Marc Sanson. Curr Opin Oncol. 2008 Nov.

Abstract

Purpose of review: Progress in molecular mechanisms and pathogenesis of malignant gliomas opens new therapeutic possibilities.

Recent findings: Recent developments in the field of tumour biology have elucidated signalling pathways and genes involved in the development of gliomas, which represent new potential therapeutic targets, and many targeted therapies are currently being tested in clinical trials. Except for the antiangiogenic drugs, the results have been modest, because of the heterogeneity of malignant gliomas and redundant pathways, suggesting that combination therapies may be more appropriate. The recent finding that only a minority of tumour cells are capable of self-renewal (tumour stem cells) leads to focus on genes specifically involved in stem cell self-renewal and proliferation.

Summary: Antiangiogenic drugs already have proved efficacy. Targeting of tumour-specific alterations and drugs more specifically directed against tumour stem cells may provide significant progress in future treatment of gliomas.

PubMed Disclaimer

Substances